je.st
news
Tag: gsk
China deports British, American investigators linked to GSK scandal
2015-06-17 16:08:39| Biotech - Topix.net
A combination photo shows British corporate investigator Peter Humphrey and his wife Yu Yingzeng as they leave the Shanghai No.1 Intermediate People's Court inside a police vehicle in Shanghai August 8, 2014. Photo: Reuters/Aly Song A British corporate sleuth and his American wife and business partner, both linked to a bribery scandal in China involving drugmaker GlaxoSmithKline PLC, were deported on Wednesday after their jail terms were reduced this month.
Tags: china
american
british
linked
GSK invests $95 million in effort to demystify cell 'operating system'
2015-06-17 06:40:03| Biotech - Topix.net
British drugmaker GlaxoSmithKline is investing $95 million to create a new U.S. research institute led by a top genomics professor to investigate how a cell's operating system works. The move reflects a commitment to fundamental research by the British company, even as its shifts emphasis to greater reliance on non-pharmaceutical businesses such as consumer healthcare and vaccines.
Tags: system
million
cell
operating
Avalon, GSK found 3 more San Diego biotechs
2015-06-16 02:15:47| Biotech - Topix.net
The new San Diego branch office of drug company GlaxoSmithKline is just off North Torrey Pines Road. Though headquartered in Philadelphia and the U.K, the company has not had a presence in Torrey Pines Mesa as it does now.
Plaintiffs, GSK Disagree Over Thalidomide Client Interviews
2015-05-28 11:12:55| Biotech - Topix.net
While GlaxoSmithKline and the plaintiffs firm leading dozens of thalidomide injury suits against the company have largely agreed on the dismissal of 31 of those claims against GSK, the pharmaceutical company is now diverging from the law firm on an attorney-client privilege issue before the Third Circuit.
Tags: client
interviews
disagree
plaintiffs
Hunt for AIDS cure accelerates as GSK and US experts link up
2015-05-11 06:06:48| Biotech - Topix.net
Britain's GlaxoSmithKline, which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS. LONDON: Britain's GlaxoSmithKline, which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] next »